Hongjun Xie相关文献与解析，生知库 | 链接生命科学的每一步

Development of a PAK4-targeting PROTAC for renal carcinoma therapy: concurrent inhibition of cancer cell proliferation and enhancement of immune cell response

开发一种靶向PAK4的PROTAC用于肾癌治疗：同时抑制癌细胞增殖并增强免疫细胞反应

doi:10.1016/j.ebiom.2024.105162

Shan Xu ，Bohan Ma ，Yanlin Jian ，Chen Yao ，Zixi Wang ，Yizeng Fan ，Jian Ma ，Yule Chen ，Xiaoyu Feng ，Jiale An ，Jiani Chen ，Ke Wang ，Hongjun Xie ，Yang Gao ，Lei Li

Dinitrogen Activation by Heteronuclear Bimetallic Cluster Anion FeV(-) in the Gas Phase

气相中异核双金属簇阴离子FeV(-)对二氮的活化

期刊:JACS Au

影响因子:8.7

doi:10.1021/jacsau.3c00143

Du, Shihu; Liu, Xuegang; Liu, Zhiling; Li, Gang; Fan, Hongjun; Xie, Hua; Jiang, Ling

发表日期：2023

文献求助收藏

Significance of platelets in the early warning of new-onset AKI in the ICU by using supervise learning: a retrospective analysis

利用监督学习方法探讨血小板在ICU新发急性肾损伤早期预警中的意义：一项回顾性分析

期刊:Renal Failure

影响因子:3

doi:10.1080/0886022X.2023.2194433

Pan, Pan; Liu, Yuhong; Xie, Fei; Duan, Zhimei; Li, Lina; Gu, Hongjun; Xie, Lixin; Lu, Xiangyun; Su, Longxiang

Neoadjuvant docetaxel and capecitabine (TX) versus docetaxel and epirubicin (TE) for locally advanced or early her2-negative breast cancer: an open-label, randomized, multi-center, phase II Trial

新辅助多西他赛联合卡培他滨（TX）与多西他赛联合表柔比星（TE）治疗局部晚期或早期HER2阴性乳腺癌：一项开放标签、随机、多中心II期试验

期刊:BMC Cancer

影响因子:3.4

doi:10.1186/s12885-022-10439-0

Yang, Houpu; Xu, Ling; Guan, Shan; Hao, Xiaopeng; Ge, Zhicheng; Tong, Fuzhong; Cao, Yingming; Liu, Peng; Zhou, Bo; Cheng, Lin; Liu, Miao; Liu, Hongjun; Xie, Fei; Wang, Siyuan; Peng, Yuan; Wang, Chaobin; Wang, Shu

Virus transmission risk of college students in railway station during Post-COVID-19 era: Combining the social force model and the virus transmission model

后疫情时代大学生在火车站的病毒传播风险：结合社会力模型和病毒传播模型

期刊:

影响因子:

doi:10.1016/j.physa.2022.128284

Cui, Hongjun; Xie, Jinping; Zhu, Minqing; Tian, Xiaoyong; Wan, Ce

微生物学

发表日期：2022

文献求助收藏

Acetylation-dependent regulation of TPD52 isoform 1 modulates chaperone-mediated autophagy in prostate cancer

TPD52 亚型 1 的乙酰化依赖性调控调节前列腺癌中的分子伴侣介导的自噬

期刊:Autophagy

影响因子:14.6

doi:10.1080/15548627.2021.1917130

Yizeng Fan ,Tao Hou ,Yang Gao ,Weichao Dan ,Tianjie Liu ,Bo Liu ,Yule Chen ,Hongjun Xie ,Zhao Yang ,Jiaqi Chen ,Jin Zeng ,Lei Li

Fiber-1, Not Fiber-2, Directly Mediates the Infection of the Pathogenic Serotype 4 Fowl Adenovirus via Its Shaft and Knob Domains

Fiber-1（而非Fiber-2）通过其轴突和球状结构域直接介导致病性4型禽腺病毒的感染。

期刊:Journal of Virology

影响因子:3.8

doi:10.1128/JVI.00954-20

Wang, Weikang; Liu, Qian; Li, Tuofan; Geng, Tuoyu; Chen, Hongjun; Xie, Quan; Shao, Hongxia; Wan, Zhimin; Qin, Aijian; Ye, Jianqiang

CD82 Suppresses ADAM17-Dependent E-Cadherin Cleavage and Cell Migration in Prostate Cancer

CD82 抑制前列腺癌中 ADAM17 依赖的 E-钙粘蛋白裂解和细胞迁移

期刊:Disease Markers

影响因子:

doi:10.1155/2020/8899924

Zhenkun Ma, Ye Gao, Wei Liu, Long Zheng, Ben Jin, Bei Duan, Hongjun Xie, Peng Guo, Jin Zeng, Ke Wang, Shan Xu, Xinyang Wang, Dalin He, Lei Li

Retrospective analysis of concurrent docetaxel and epirubicin neoadjuvant versus adjuvant chemotherapy: Which leads to better outcomes for different subtype breast cancer patients?

回顾性分析多西他赛联合表柔比星新辅助化疗与辅助化疗：哪种方案能为不同亚型乳腺癌患者带来更好的疗效？

期刊:Medicine

影响因子:1.4

doi:10.1097/MD.0000000000012690

Yang, Houpu; Zhou, Lixin; Wang, Shu; Cao, Yingming; Tong, Fuzhong; Liu, Peng; Zhou, Bo; Cheng, Lin; Liu, Miao; Liu, Hongjun; Xie, Fei; Guo, Jiajia; Wang, Siyuan; Peng, Yuan

A complete telomere-to-telomere assembly of Oryza sativa L. subsp. indica Kato T197 genome

水稻（Oryza sativa L. subsp. indica）Kato T197基因组的完整端粒到端粒组装

Development of a PAK4-targeting PROTAC for renal carcinoma therapy: concurrent inhibition of cancer cell proliferation and enhancement of immune cell response

开发一种靶向PAK4的PROTAC用于肾癌治疗：同时抑制癌细胞增殖并增强免疫细胞反应

Dinitrogen Activation by Heteronuclear Bimetallic Cluster Anion FeV(-) in the Gas Phase

气相中异核双金属簇阴离子FeV(-)对二氮的活化

Significance of platelets in the early warning of new-onset AKI in the ICU by using supervise learning: a retrospective analysis

利用监督学习方法探讨血小板在ICU新发急性肾损伤早期预警中的意义：一项回顾性分析

Neoadjuvant docetaxel and capecitabine (TX) versus docetaxel and epirubicin (TE) for locally advanced or early her2-negative breast cancer: an open-label, randomized, multi-center, phase II Trial

新辅助多西他赛联合卡培他滨（TX）与多西他赛联合表柔比星（TE）治疗局部晚期或早期HER2阴性乳腺癌：一项开放标签、随机、多中心II期试验

Virus transmission risk of college students in railway station during Post-COVID-19 era: Combining the social force model and the virus transmission model

后疫情时代大学生在火车站的病毒传播风险：结合社会力模型和病毒传播模型

Acetylation-dependent regulation of TPD52 isoform 1 modulates chaperone-mediated autophagy in prostate cancer

TPD52 亚型 1 的乙酰化依赖性调控调节前列腺癌中的分子伴侣介导的自噬

Fiber-1, Not Fiber-2, Directly Mediates the Infection of the Pathogenic Serotype 4 Fowl Adenovirus via Its Shaft and Knob Domains

Fiber-1（而非Fiber-2）通过其轴突和球状结构域直接介导致病性4型禽腺病毒的感染。

CD82 Suppresses ADAM17-Dependent E-Cadherin Cleavage and Cell Migration in Prostate Cancer

CD82 抑制前列腺癌中 ADAM17 依赖的 E-钙粘蛋白裂解和细胞迁移

Retrospective analysis of concurrent docetaxel and epirubicin neoadjuvant versus adjuvant chemotherapy: Which leads to better outcomes for different subtype breast cancer patients?

回顾性分析多西他赛联合表柔比星新辅助化疗与辅助化疗：哪种方案能为不同亚型乳腺癌患者带来更好的疗效？